We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Amplidiag® Easy Receives CE-IVD Mark
Product News

Amplidiag® Easy Receives CE-IVD Mark

Amplidiag® Easy Receives CE-IVD Mark
Product News

Amplidiag® Easy Receives CE-IVD Mark


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Amplidiag® Easy Receives CE-IVD Mark"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Mobidiag Ltd, has announced the CE-IVD marking of Amplidiag® Easy, a proprietary system allowing nucleic acid extraction and PCR setup directly from stool samples. The Amplidiag® Easy provides users with an automated solution accelerating the sample to result time. As the system runs directly from stool primary sample tubes to PCR setup, no manual intervention is required. Moreover, the Amplidiag® Analyzer software can transfer data directly between the Amplidiag® Easy and PCR instruments simplifying greatly the overall workflow.


The platform is specifically designed for and compatible with Mobidiag´s Amplidiag® product line, a suite of IVD tests for gastrointestinal infections.


“Amplidiag® Easy sets a new standard for multiplex assays in gastrointestinal infections as it allows labs to overcome their main challenges: improve cost-efficiency by reducing hands-ontime and increase sample throughput with automation. In that perspective, we are very pleased to see the adoption of our first platform by the renowned Finnish lab Yhtyneet Medix Laboratoriot for their routine diagnostic screen” said Tuomas Tenkanen, CEO at Mobidiag.

Advertisement